LEXX   $3.12  -4.29% Market Closed After Close 3.1983 2.51%

Lexaria Bioscience Corp
Total Cash 8.51M
totalCashPerShare 0.538
EBITDA -4.53M
Total Debt 142.59K
quickRatio 55.841
currentRatio 58.273
Total Revenue 411.02K
debtToEquity 1.463
Revenue/Share 0.039
ROA -0.38211
ROE -0.70655996
grossProfits
freeCashflow -3.21M
operatingCashflow -4.69M
earningsGrowth
revenueGrowth 0.081
grossMargins 0.98827004
ebitdaMargins 0.0
operatingMargins -20.74904
profitMargins 0.0
enterpriseValue 45.49M
forwardPE -8.51282
floatShares 12.64M
sharesOutstanding 15.81M
sharesShort 241.74K
sharesShortPriorMonth 216.45K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.13%
Short Ratio help_outline 0.99%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 0.64
Price To Book help_outline 5.19
earningsQuarterlyGrowth
netIncomeToCommon -4.85M
trailingEps -0.44%
forwardEps -0.39%
enterpriseToEbitda -10.03
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.11 3Q 2024
institutionsCount 28
lastUpdated Sept. 16, 2024, 8:10 p.m.